These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9607560

  • 1. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
    Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A.
    Cell Growth Differ; 1998 May; 9(5):393-404. PubMed ID: 9607560
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K, Sheng H, Shao J, Beauchamp RD.
    Exp Cell Res; 2001 Jun 10; 266(2):239-49. PubMed ID: 11399052
    [Abstract] [Full Text] [Related]

  • 3. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 4. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH, He W, Olson KL, Wang XJ.
    Cancer Res; 2001 Oct 15; 61(20):7435-43. PubMed ID: 11606377
    [Abstract] [Full Text] [Related]

  • 5. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E.
    Cell Growth Differ; 1995 Dec 01; 6(12):1635-42. PubMed ID: 9019169
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.
    Frontelo P, González-Garrigues M, Vilaró S, Gamallo C, Fabra A, Quintanilla M.
    Exp Cell Res; 1998 Nov 01; 244(2):420-32. PubMed ID: 9806792
    [Abstract] [Full Text] [Related]

  • 8. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 9. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 10. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N, Imai J, Watanabe M, Hiroi N, Sugano S, Yoshino G.
    Horm Metab Res; 2006 Mar 15; 38(3):159-66. PubMed ID: 16673206
    [Abstract] [Full Text] [Related]

  • 11. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA, Maruyama H, Kusama T, Ralli S, Korc M.
    Clin Cancer Res; 2001 Sep 15; 7(9):2931-40. PubMed ID: 11555612
    [Abstract] [Full Text] [Related]

  • 12. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype.
    Caulín C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M.
    Cell Growth Differ; 1995 Aug 15; 6(8):1027-35. PubMed ID: 8547217
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
    Gold LI, Jussila T, Fusenig NE, Stenbäck F.
    J Pathol; 2000 Apr 15; 190(5):579-88. PubMed ID: 10727984
    [Abstract] [Full Text] [Related]

  • 14. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 15. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
    Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M.
    Surgery; 2004 Aug 03; 136(2):364-74. PubMed ID: 15300203
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
    Cancer Res; 2008 Mar 01; 68(5):1388-97. PubMed ID: 18316602
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K, Cornelius SC, Danielpour D.
    Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605
    [Abstract] [Full Text] [Related]

  • 18. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
    Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T.
    Br J Cancer; 1999 Aug 01; 80(11):1708-17. PubMed ID: 10468286
    [Abstract] [Full Text] [Related]

  • 19. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 20. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C.
    Oncogene; 1994 May 15; 9(5):1479-85. PubMed ID: 8152811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.